Baxter International (BAX) Tops Q4 Earnings and Revenue Estimates
Baxter International (BAX) came out with quarterly earnings of $0.88 per share, beating the Zacks Consensus Estimate of $0.86 per share. This compares to earnings of $0.88 per share a year ago.
Medical device maker Baxter beats sales and profit estimates on strong demand
Baxter International beat Wall Street expectations for fourth-quarter sales and profit on Thursday on strong demand for its medical devices and improvements in the supply chain environment.
Strategist: Buy Baxter stock, skip Eli Lilly stock
Novo Nordisk (NVO) was named Yahoo Finance's Company of the Year thanks to the success of its diabetes and weight loss drugs, Ozempic and Wegovy. But there are other ways you can play the GLP-1 hype.
Baxter International: A Cheap Big Pharma Stock With Improving Earnings And +3% Dividend Yield
Baxter International stock rated Buy, agreeing with Wall Street consensus. Tailwinds coming from positive revenue, earnings, and equity growth. Cheap share price below moving average combined with ...
Baxter (BAX) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
The headline numbers for Baxter (BAX) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wall Street est...
Baxter International beats Q3 profit estimates on strong demand for medical devices
Baxter International on Thursday beat Wall Street expectations for third-quarter revenue and profit, as a recovery in surgical procedure volumes after the pandemic helped drive the demand for its m...
BAX vs. SYK: Which Stock Is the Better Value Option?
Investors looking for stocks in the Medical - Products sector might want to consider either Baxter International (BAX) or Stryker (SYK). But which of these two stocks is more attractive to value in...
Baxter (BAX) to Report Q3 Earnings: Is a Beat in Store?
Baxter's (BAX) third-quarter results are likely to reflect growth in elective surgical procedures, offset by currency movement. Hillrom's products might have boosted sales.
Baxter's (BAX) New Launch to Enable Earlier Treatment of Eye
Baxter's (BAX) latest offering is likely to enable a more digitally-connected primary care examination and support faster diagnosis for earlier treatment of eye conditions.
What other industries could weight loss drugs disrupt?
Jared Holz, Mizuho health care sector strategist, joins the ‘Fast Money' traders to discuss Novo Nordisj's kidney trial outcomes and the impact of weight loss drugs on the health care sector.
Why Investors Punished Baxter International Stock Today
A drug made by a rival tested well in a clinical trial for kidney disease. That treatment is currently a very hot product, but for different indications.
The 3 Widest Competitive Moats on Wall Street
Competitive moats symbolize a company's sustainable advantage, protecting it from competitors and external threats. Three standout examples illustrate this principle vividly.
Reasons to Retain Baxter International (BAX) in Your Portfolio
Baxter International's (BAX) robust growth across all geographies, along with transformational initiatives, boosts confidence. However, pandemic-related disruption continues to hurt sales.
Baxter to Present at Morgan Stanley 21st Annual Global Healthcare Conference
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Morgan Stanley 21st Annual Global Healthcare Conference on Wednesday, September ...
Will Baxter Stock Recover To Its Pre-Inflation Shock Highs?
Although there has been a steady decline in the inflation rate in response to the Fed's aggressive rate hike plan, investors still have concerns about a potential rece
Related Companies